2021
DOI: 10.1111/hepr.13603
|View full text |Cite
|
Sign up to set email alerts
|

Angiopoietin‐like protein 4 deficiency augments liver fibrosis in liver diseases such as nonalcoholic steatohepatitis in mice through enhanced free cholesterol accumulation in hepatic stellate cells

Abstract: Aim : We recently reported that lipoprotein lipase (LPL)-mediated free cholesterol (FC) accumulation in hepatic stellate cells (HSCs) augmented liver fibrosis in nonalcoholic steatohepatitis (NASH). The aim of the present study was to explore the role of angiopoietin-like protein 4 (Angptl4), an LPL inhibitor, in the pathogenesis of liver fibrosis in NASH.Methods: Angptl4-deficient or wild-type mice were used to investigate the role of Angptl4 in the pathogenesis of NASH induced by feeding a methionine-and ch… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(2 citation statements)
references
References 31 publications
0
2
0
Order By: Relevance
“…In addition, ANGPTL4 upregulates cholesterol synthesis in the liver secondary to inhibition of LPL- and HL-dependent hepatic cholesterol uptake [ 58 ]. Accordingly, decreased ANGPTL4 expression might be associated with suppression of LN hepatic cholesterol synthesis, with which decreased HSD11B1 expression could be associated [ 59 ].…”
Section: Discussionmentioning
confidence: 99%
“…In addition, ANGPTL4 upregulates cholesterol synthesis in the liver secondary to inhibition of LPL- and HL-dependent hepatic cholesterol uptake [ 58 ]. Accordingly, decreased ANGPTL4 expression might be associated with suppression of LN hepatic cholesterol synthesis, with which decreased HSD11B1 expression could be associated [ 59 ].…”
Section: Discussionmentioning
confidence: 99%
“…Angptl4 upregulates liver cholesterol synthesis via inhibition of lipoprotein lipase (LPL)- and hepatic lipase (HL)-dependent hepatic cholesterol uptake( 15 ). Angptl4 is upregulated in liver cirrhosis patients, and whole-body Angptl4 deficiency augments liver fibrosis in a murine methionine-choline deficient diet-induced NASH model through enhanced free cholesterol accumulation in hepatic stellate cells (HSCs)( 16 ). On the other hand, in vivo overexpression of Angptl4 by an adenoviral vector in high-fat diet (HFD)-fed mice improves glucose tolerance and insulin resistance but induces liver steatosis( 17 ).…”
Section: Introductionmentioning
confidence: 99%